Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q4 2016 call → NOWe need to determine if management explains where the company's business is going by narrating what its counterparties are themselves doing and scaling. The key is whether management's forward account is substantially about the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' own trajectories. Let's analyze the transcript. The call covers BP's Q4 2016 results. Management discusses various aspects: cost reductions, capital expenditure, portfolio additions, project start-ups, downstream performance, etc. The forward-looking statements are about BP's own projects, cost targets, and portfolio. They mention acquisitions like Abu Dhabi ADCO, Zohr, Mauritania/Senegal, Woolworths, etc. But do they narrate counterparties' own trajectories? For example, they talk about the Abu Dhabi concession renewal, but that's a concession they acquired, not a counterparty's expansion. They talk about Zohr as a gas field they bought a share in, but they don't describe Eni's or Egypt's own build-out as the driver. They mention Woolworths as a partnership, but that's a retail acquisition, not a counterparty scaling. The question is about whether management explains the company's direction by reporting on the growth of specific customers/partners they already serve. For instance, if they said "our customer is building new plants, so our volumes will increase," that would be it. Here, management talks about their own projects, their own cost reductions, their own portfolio. They mention "we have six major project start-ups" etc. They talk about OPEC and market rebalancing, but that's macro. They talk about their own divestments and acquisitions. There is a mention of "Aker BP" as a merger, but that's a joint venture. They talk about "our partnership with Woolworths" but that's a new acquisition, not an existing counterparty scaling. They talk about "our strategic partnership with Fulcrum BioEnergy" but that's a new partnership, not a scaling of an existing one. The essence of the question: Does management's forward account consist of reporting on the growth of specific counterparties they already supply? I don't see that.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.